Please login to the form below

Not currently logged in
Email:
Password:

osteoarthritis drug

This page shows the latest osteoarthritis drug news and features for those working in and with pharma, biotech and healthcare.

Galapagos mid-stage trial failure raises concerns for Gilead deal

Galapagos mid-stage trial failure raises concerns for Gilead deal

Investigational osteoarthritis treatment misses primary endpoint in phase 2 study. Biotech company Galapagos has reported some disappointing results for its investigational osteoarthritis drug GLPG1972, raising doubts about the prospects of its

Latest news

More from news
Approximately 0 fully matching, plus 15 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...